Our data showed that CD161 is reduced in early, untreated RA patients, combined with the observation that CD3+MR1-tet+ cell frequencies were similar in patients and controls, suggests that the MAIT composition and phenotype is altered rather than an actual loss of MAIT cells. This evidence concerns the gene KLRB1 and rheumatoid arthritis.